Disclosure: KibbleIQ is reader-supported. When you buy through affiliate links on this page (such as “Shop on Amazon” buttons), we may earn a commission at no extra cost to you. Our rankings are not influenced by commissions — we score every product using our published methodology before any commercial relationship is considered. See our editorial standards.
Short answer: Feline hepatic encephalopathy (HE) is neurologic dysfunction — lethargy, head-pressing, ataxia, seizures, hypersalivation, blindness — driven by circulating ammonia and other gut-derived neurotoxins that a failing liver cannot clear. Two main feline presentations: congenital portosystemic shunts (PSS), which account for the majority of young-cat HE cases per Tobias 2003 (most common in Himalayan, Persian, and mixed-breed kittens under 2 years), and acquired HE from advanced hepatic disease — cirrhosis, severe cholangiohepatitis, end-stage hepatic lipidosis — in adult or senior cats. Unlike the older dog-centric paradigm of severe protein restriction, current feline HE management per Center 2007 and Lidbury 2016 favors moderate-protein feeding (30–35% ME from high-quality animal protein), highly-digestible carbohydrate for caloric substitution, lactulose to trap ammonia in the colon, and antibiotic therapy (metronidazole, neomycin) to reduce gut ammonia-producing bacteria. Prescription diets (Hill’s Rx l/d Feline, Royal Canin Hepatic Feline, Purina Pro Plan Veterinary Diets NF Feline) are first-line. The commercial picks below work only for stable-phase maintenance following clinical-phase management, and only in coordination with your veterinary team. Surgical correction of PSS is curative when anatomically feasible; until surgery or in non-surgical cases, dietary plus pharmacologic management carries the workload.

How We Ranked These

Every food on this list was scored using KibbleIQ’s ingredient analysis rubric, which evaluates protein quality, filler content, preservative safety, and ingredient transparency on a 0–100 scale. For feline hepatic encephalopathy specifically, we cross-referenced Center 2007 (comprehensive feline liver disease review), Lidbury 2016 (canine-and-feline HE updated management), Tobias 2003 (PSS breed prevalence in cats), Hill 1996 (feline protein requirement 4–5x higher than canine per obligate carnivore metabolism), Norris 2013 (feeding-access and tube-feeding protocols), Biourge 1993 (feline recovery protein requirement), Armstrong 2009 (assisted feeding critical-care protocol), Dimski 1994 (liver-disease nutrition), Rothuizen 2006 (liver disease staging), Zoran 2002 (feline obligate carnivore framework that argues against severe protein restriction), AAFP 2016 Senior Care (older-cat hepatic-disease demographic), WSAVA Global Nutrition Guidelines, and NRC 2006 cat nutrient requirements. We also considered Berent 2012 (interventional PSS treatment review) and Otomo 2020 (feline PSS outcomes with medical-only vs. surgical management).

The critical feline-specific caveat — and the reason this guide leans toward moderate-protein maintenance rather than the severe protein restriction classically used in canine HE — is that cats are obligate carnivores whose gluconeogenic pathway runs continuously on amino-acid substrate per Zoran 2002. Cats cannot downregulate hepatic protein metabolism the way dogs and humans can; severe protein restriction in cats drives muscle catabolism and worsens outcomes per Center 2007. The current feline HE management emphasis is moderate-protein (NOT low-protein) + high-quality-bioavailable-protein + branched-chain-amino-acid preservation + pharmacologic lactulose + antibiotic ammonia-reduction + hepatoprotective antioxidants (SAMe, silybin/milk thistle, vitamin E). Diet alone does not manage HE; diet alongside veterinary pharmacologic management can.

Our Top 5 Picks (Stable-Phase Maintenance)

1. Hill’s Science Diet Adult Indoor — C (60/100)
Hill’s Science Diet Adult Indoor is our lead commercial pick for stable-phase feline HE maintenance because Hill’s product-line science has closer alignment with the broader veterinary-prescription-hepatic framework than most premium OTC formulations. Moderate protein (~31% DM), highly digestible, with consistent ingredient sourcing across lots. Our rubric scores this pick in the C range because the protein sourcing is moderate rather than premium-grade, but for HE cats specifically the moderate-protein profile is the clinical priority over high-protein-score rubric positioning. The Hill’s Rx l/d Hepatic Feline prescription line remains the first-line clinical standard — this OTC pick sits adjacent for stable-phase maintenance after transition away from prescription diet if the veterinary team approves.

Best commercial pick when transitioning away from prescription hepatic diet with veterinary approval. Read our full Hill’s Science Diet Cat review → · Shop on Amazon →

2. Iams Proactive Health Cat — C (62/100)
Iams Proactive Health is our budget-accessible stable-phase pick, providing moderate-protein (~31% DM) chicken-based formulation with beet-pulp fiber that supports the gut-motility side of HE management (lactulose works better when gut transit is normal; delayed-transit constipated cats have worse HE control because ammonia-producing bacteria have longer contact time with amino-acid substrate). Beet pulp is a moderate-fermentability soluble fiber that supports colonic ammonia trapping alongside lactulose. For owners of HE cats where the monthly cost of Hill’s prescription formulations is prohibitive, Iams provides a reasonable stable-maintenance option.

Best budget stable-phase option with fiber support for gut motility. Read our full Iams Cat review → · Shop on Amazon →

3. Royal Canin Kitten — C (58/100)
Royal Canin Kitten is specifically positioned for the young-cat feline-PSS demographic — Tobias 2003 documented median age at PSS diagnosis of 6–12 months in cats, and the breeds most affected (Himalayan, Persian, Siamese, mixed-breed kittens) fall within kitten-life-stage feeding. The highly-digestible formulation with small kibble size aids voluntary intake in PSS cats with malaise and failure-to-thrive. Moderate protein with rice-and-corn carbohydrate base provides caloric substitution for protein-sparing metabolism. For PSS cats awaiting surgical correction at 3–6 months post-diagnosis, this is an appropriate bridge-diet choice.

Best pick for young PSS cats awaiting surgical shunt correction. Read our full Royal Canin Kitten review → · Shop on Amazon →

4. Purina Pro Plan Adult Cat — C (56/100)
Purina Pro Plan Adult is a moderate-protein commercial standard with strong lot-to-lot consistency — important for HE cats where formulation changes can produce unpredictable ammonia response. Corn-and-rice carbohydrate base provides caloric substitution; probiotic supplementation supports gut microbial ecology relevant for ammonia-producing-bacteria modulation. Our rubric scores this in the C range based on ingredient transparency and fat/filler profile, but the stable-phase HE priority is moderate-protein consistency rather than premium-sourcing rubric optimization. Widely available through most retailers and Chewy.

Best commercial-availability stable-phase pick with consistent formulation. Read our full Purina Pro Plan Cat review → · Shop on Amazon →

5. Rachael Ray Nutrish Cat — C (58/100)
Rachael Ray Nutrish Indoor Complete is a grocery-retail-accessible moderate-protein pick for HE-cat owners whose local pet-specialty store carries limited Hill’s prescription selection. Chicken-primary protein with corn-gluten-meal and brown-rice carbohydrate base provides the same caloric-substitution profile as other mid-tier picks. For cats whose HE is stable on medical management and whose feeding adherence depends on grocery-retail accessibility, Rachael Ray sits alongside Iams and Purina Pro Plan as workable stable-phase options.

Best grocery-retail-accessible stable-phase option. Read our full Rachael Ray Nutrish Cat review → · Shop on Amazon →

What to Look for in Food for a Cat with Hepatic Encephalopathy

Prescription hepatic diets remain the first-line clinical standard. Per Center 2007, Lidbury 2016, and AAFP 2016, Hill’s Rx l/d Hepatic Feline, Royal Canin Hepatic Feline, and Purina Pro Plan Veterinary Diets NF Feline are the three clinical-trial-supported hepatic-disease prescription formulations for cats. These combine moderate-but-high-quality protein, additional dietary fiber (lactulose-synergy), L-carnitine + taurine supplementation, antioxidants (vitamin E, SAMe precursors in some formulations), and consistent batch-level formulation. For the acute-phase or active-HE cat, these prescription diets should remain in place under veterinary supervision. The commercial picks above work for stable-phase maintenance only when the veterinary team approves transition — not as a DIY alternative to prescription feeding for newly-diagnosed HE cats.

Moderate-protein, NOT low-protein — the feline-specific distinction. Per Zoran 2002 and Center 2007, the outdated severe-protein-restriction paradigm (30–50% protein calorie reduction) used historically in canine HE is contraindicated in cats. Cats are obligate carnivores whose gluconeogenic metabolism runs on amino acid substrate even in caloric sufficiency; severe protein restriction produces muscle catabolism, worsens ammonia generation from endogenous protein breakdown, and accelerates HE decompensation. Current feline HE management targets moderate protein at ~30–35% ME from high-quality bioavailable animal sources, with branched-chain amino acid preservation (BCAAs compete with aromatic amino acids for blood-brain-barrier transport and theoretically reduce HE severity). Do not DIY low-protein feeding for a feline HE cat without veterinary guidance — the approach that works in dogs is actively harmful in cats.

Lactulose is a central pharmacologic adjunct, not a dietary one. Per Center 2007 and Lidbury 2016, lactulose (a non-absorbable disaccharide) is the primary pharmacologic tool for feline HE. Mechanism: colonic bacteria ferment lactulose to lactic acid, trapping ammonia as non-absorbable ammonium, and the osmotic effect speeds gut transit to reduce ammonia-producing-bacteria contact time. Dosing is titrated to produce 2–3 soft stools per day; too much produces diarrhea and dehydration, too little allows ammonia escape. Lactulose is prescribed by your veterinarian, not selected via diet. Diet supports the gut-motility side (fiber-inclusive formulations aid lactulose efficacy); lactulose carries the ammonia-trapping work. Concurrent metronidazole or neomycin antibiotic therapy reduces ammonia-producing gut bacteria. The triad of diet + lactulose + antibiotics is the medical-management standard.

PSS surgery is curative when anatomically feasible — bridge-feeding matters for the 1–6 month window. Per Tobias 2003, Berent 2012, and Otomo 2020, surgical closure of congenital portosystemic shunts in cats is curative in approximately 70–90% of anatomically-accessible extrahepatic shunts, with survival extension to near-normal feline lifespan. Intrahepatic and complex shunts have lower surgical success rates and more frequently require medical-only management. The 1–6-month window between PSS diagnosis and surgical correction (or medical-only commitment for non-surgical cases) is when feeding and pharmacologic management matter most. Our Royal Canin Kitten pick is specifically oriented to the young-cat PSS surgical-bridge demographic; other picks are adult-maintenance-focused. For broader kitten-feeding framework beyond PSS-specific considerations, see our kittens guide.

HE in adult cats signals end-stage liver disease — distinct from PSS framework. Per Center 2007 and Rothuizen 2006, adult-onset feline HE typically represents end-stage chronic hepatic disease: advanced cirrhosis, severe cholangiohepatitis/cholangitis, end-stage hepatic lipidosis with ongoing inflammation, or rare hepatic neoplasia with extensive parenchymal involvement. Prognosis differs markedly from PSS: median survival with medical management for adult cirrhotic HE is typically weeks to months rather than years. The feeding priority shifts toward palliative quality-of-life maintenance with adequate caloric density and tolerable protein. Our hepatic lipidosis recovery guide (Session 21) covers the specific acute-lipidosis-to-recovery framework, which can progress to chronic HE in unresolved severe cases. Our triaditis guide (Session 21) covers concurrent IBD + pancreatitis + cholangitis that can progress to cholangiohepatitis-driven HE. Our inappetence guide covers the feeding-tolerance challenges common in all three scenarios.

Watch for the IBD and hyperthyroid overlap in senior-cat HE presentations. Per AAFP 2016 Senior Care and Lidbury 2016, senior cats with HE often have concurrent chronic GI inflammatory disease contributing to gut dysbiosis and ammonia generation. Treatment of the underlying inflammatory disease (prednisolone for IBD, I-131 or methimazole for hyperthyroid, treated concurrently with HE management) can substantially improve HE control. Our IBD guide covers the feline IBD feeding framework alongside medical management; our hyperthyroidism guide (Session 20) covers the endocrine-management side; our chronic vomiting guide (Session 19) covers the bile-reflux pattern that can coexist with early-stage hepatic disease. For senior-cat kidney comorbidities that often complicate HE in older cats, our senior kidney guide covers the concurrent CKD angle.

Bottom Line

Feline hepatic encephalopathy reflects advanced hepatic dysfunction or congenital portosystemic shunting, and dietary management differs importantly from the older dog-centric severe-protein-restriction paradigm: cats need moderate (NOT low) protein per Zoran 2002 + Center 2007, high-bioavailable animal sourcing, with concurrent pharmacologic lactulose + antibiotic therapy + hepatoprotective supplementation carrying the medical workload. Prescription hepatic diets (Hill’s Rx l/d Feline, Royal Canin Hepatic, Purina Pro Plan Veterinary NF) remain first-line. Our commercial stable-phase maintenance picks for veterinary-approved transition: Hill’s Science Diet Adult Indoor leads with closest-to-prescription commercial positioning; Iams Proactive Health provides budget-accessible fiber-supported maintenance; Royal Canin Kitten covers the young-cat PSS surgical-bridge demographic; Purina Pro Plan Adult Cat offers formulation-consistency advantages; Rachael Ray Nutrish covers grocery-retail accessibility. Coordinate all HE management with your veterinary team — diet alone does not manage HE, and feline-specific moderate-protein dietary rules differ from canine paradigms in ways that matter clinically.